Good Call.
- Can they allude to their preference moving forward when they would like big Pharma to become involved? Sooner rather than later and if it would be to partial fund or fully fund trials. Or, do they wish to fund the next round of trials themselves and then look for an even better deal? See if you can get any indication of time line intent and to what extent they'd prefer big Pharma's involvement.
- Would they provide their estimate of the current value of BOT if Pharma came along within the next 2-4 months.
- The reasons why and best possible outcomes they are hoping for from there upcoming Advisory Board Meeting in Milan?
- When will they start the PR train showcasing some of the results and liaising with media?
Thanks. Can't hurt to ask.
Good Call. - Can they allude to their preference moving forward...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |